03:03:48 EDT Tue 17 Jun 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:ONC - ONCOLYTICS BIOTECH INC. - https://www.oncolyticsbiotech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ONC - T  0.50.86·0.882.50.88+0.067.3348.42803890.80  0.88  0.792.08  0.445Jun 16May 1415 min RT 2¢
TSX - T0.50.86·0.882.50.87+0.056.1194.61581710.80  0.88  0.802.08  0.445Jun 1615 min
NEO ATS - U 0.88+0.067.331.526310.82  0.88  0.82Jun 1615 min
Alpha - A 0.87+0.056.114.01160.81  0.87  0.81Jun 1615 min
Omega - O 0.88+0.067.327.522210.79  0.88  0.79Jun 1615 min
Pure - P 0.87+0.056.12.6260.79  0.87  0.79Jun 1615 min
Chi-X - X 0.87+0.056.149.541230.80  0.88  0.80Jun 1615 min
CX2 - H 0.88+0.067.311.09150.79  0.88  0.79Jun 1615 min
CXD - D 0.825.7354    Jun 1315 min
TriAct - M 0.826.8451    Sep 11/2015 min
Lynx - Y 0.86+0.044.95.0480.80  0.87  0.80Jun 1615 min
CS2 - S 0.820.303    Jun 1115 min

Recent Trades - Last 10 of 389
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:30U0.880.061,0001 Anonymous79 CIBCK
15:59:30U0.880.061,0001 Anonymous1 AnonymousK
15:57:33M0.880.061007 TD Sec7 TD SecE
15:55:10X0.870.0550079 CIBC79 CIBCK
15:55:10T0.870.051,00079 CIBC79 CIBCK
15:52:36X0.880.061,0001 Anonymous79 CIBCK
15:52:36X0.880.062,0001 Anonymous79 CIBCK
15:52:36T0.880.062,0001 Anonymous79 CIBCK
15:52:36H0.880.061,00079 CIBC79 CIBCK
15:52:36T0.870.0550079 CIBC79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-05-14 16:52C:ONC0.71SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-14 16:52C:ONC0.71SEDAR Interim MD & ASEDAR Interim MD & A
2025-03-11 09:10C:ONC0.895In the NewsGlobe says Miehm reaffirms Oncolytics at "outperform"
2025-03-07 13:28C:ONC1.08SEDAR Annual ReportSEDAR Annual Report
2025-03-07 13:23C:ONC1.08SEDAR MD & ASEDAR MD & A
2025-03-07 13:17C:ONC1.08SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-02-25 09:27C:ONC1.02News ReleaseOncolytics Biotech to hold 2024 results call March 7
2025-02-19 17:59C:ONC1.03News ReleaseOncolytics gets green light to continue study enrolment
2025-01-22 08:30C:ONC1.185News ReleaseDemand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
2024-12-26 09:00C:ONC1.41News ReleaseAchievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook
2024-12-18 08:45C:ONC1.13News ReleasePromising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
2024-11-12 10:04C:ONC1.49SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-12 10:03C:ONC1.49SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-01 17:14C:ONC1.48SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-01 17:07C:ONC1.48SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-07-12 16:38C:ONC1.44SEDAR Preliminary Short Form ProspectusSEDAR Preliminary Short Form Prospectus
2024-07-12 11:05C:ONC1.44SEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus